JUL 28, 2014 12:00 AM PDT

Cortellis Reaches Milestone

WRITTEN BY: Ilene Schneider
The Intellectual Property and Science business of Thomson Reuters, a leading provider of intelligent information for businesses and professionals, announced that Cortellis Clinical Trials Intelligence, its global clinical-drug-trial intelligence database, marked an industry-first milestone with the documentation of more than 180,000 clinical trials.

The database is designed to provide pharmaceutical professionals with greater and quicker access to critical data and strategic insights to build stronger, more effective clinical trials. Launched in August 2013, it is part of the Cortellis suite, a source of life sciences intelligence information and analytics across multiple disciplines including regulatory, business development, discovery and pre-clinical.

Thomson Reuters' Cortellis Clinical Trials Intelligence gives life science professionals access to information and analytics from more than 180,000 global clinical trials, including coverage of drugs, biologics, diagnostics, biomarkers and medical devices, supporting a wide range of outcome searching. Cortellis users can gain deeper scientific and competitive insights by connecting clinical trial data with drug pipelines, patents, pre-clinical insights and biomarkers on a single, unified platform, reducing time spent compiling and analyzing clinical information, and to ultimately construct better trials. The information can also be accessed through APIs embedded in a customer's existing workflow or third-party software applications.

"We are proud to have reached this significant industry milestone within the first year of releasing Cortellis Clinical Trials Intelligence," said Jon Brett-Harris, managing director, Thomson Reuters IP & Science. "This rapid development is a reflection of our continued commitment to provide the best available information to support the pharmaceutical industry in driving successful clinical trials."

Cortellis Clinical Trial Intelligence makes program planning and competitive research simpler and more efficient as the number of clinical trials in the database continues to grow. The solution also allows users to discover competitor strategies for specific patient segments, biomarker utilization, end points and novel insights into disease processes and to uncover vital connections by integrating their internal, proprietary data with the wide variety of reference information available through Cortellis.

Thomson Reuters is a leading source of intelligent information for businesses and professionals. The company combines industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by a long-established's most trusted news organization.
About the Author
Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
MAY 08, 2022
Microbiology
A Relative of Some of the World's Deadliest Viruses is Found in Europe
MAY 08, 2022
A Relative of Some of the World's Deadliest Viruses is Found in Europe
African fruit bats are the natural hosts of Marburg and Ebola viruses, both of which are filoviruses. These RNA viruses ...
MAY 09, 2022
Health & Medicine
What's the Best Amount of Sleep in Middle and Old Age?
MAY 09, 2022
What's the Best Amount of Sleep in Middle and Old Age?
Poor and erratic sleep patterns are thought to contribute to cognitive decline and psychiatric disorders in older age. R ...
MAY 13, 2022
Drug Discovery & Development
Opioid Addiction Treatments Minimize Fetal Brain Changes
MAY 13, 2022
Opioid Addiction Treatments Minimize Fetal Brain Changes
The rise in opioid use, addiction, and overdose is a serious public health matter. Almost 850,000 people have died of dr ...
MAY 23, 2022
Clinical & Molecular DX
How Antibiotics Can Lead to a Persistent Fungal Infection
MAY 23, 2022
How Antibiotics Can Lead to a Persistent Fungal Infection
A new study from the University of Birmingham and National Institutes of Health has shown that patients who are prescrib ...
MAY 25, 2022
Neuroscience
The Connection Between Bizarre Dreams and Deeper Learning
MAY 25, 2022
The Connection Between Bizarre Dreams and Deeper Learning
A study published in eLife found that wakefulness, non-REM, and REM sleep have complementary functions for learning. Uni ...
MAY 25, 2022
Cannabis Sciences
NYU Researchers Find CBD effectively Reduces Post Operative Pain
MAY 25, 2022
NYU Researchers Find CBD effectively Reduces Post Operative Pain
  An NYU research study found that a cannabidiol (CBD) tablet safely and effectively reduced post-operative pain. T ...
Loading Comments...